1. Validating the CHAMPS Score: A Novel and Reliable Prognostic Score of Non-Variceal Upper Gastrointestinal Bleeding
- Author
-
Lam HT, Nguyen TD, Bui HH, and Vo TD
- Subjects
non-variceal upper gastrointestinal bleeding ,champs ,mortality prediction ,risk scores ,gbs. ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Huong Tu Lam,1 Thang Dinh Nguyen,2 Hoang Huu Bui,1 Thong Duy Vo1,3 1Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Department of Gastroenterology, Cho Ray Hospital, Ho Chi Minh City, Vietnam; 3Department of Gastroenterology, University Medical Center Ho Chi Minh City, Ho Chi Minh City, VietnamCorrespondence: Thong Duy Vo, Department of Gastroenterology, University Medical Center Ho Chi Minh City, 215 Hong Bang, Ward 11, Dis. 5, Ho Chi Minh City, 72714, Vietnam, Tel +84 932039888, Email thong.vd@umc.edu.vnIntroduction: The Charlson Comorbidity Index ≥ 2, in-Hospital onset, Albumin < 2.5 g/dL, altered Mental status, Eastern Cooperative Oncology Group Performance status ≥ 2, Steroid use (CHAMPS) score is a novel and promising prognostic tool. We present an initial external validation of the CHAMPS score for predicting mortality in acute nonvariceal upper gastrointestinal bleeding (NVUGIB) across multiple clinical outcomes.Methods: A prospective cohort study was conducted on adult patients with NVUGIB admitted to the Department of Gastroenterology between November 2022 and June 2023. The CHAMPS score performance in predicting in-hospital outcomes was evaluated by employing area under the receiver operating characteristic (AUROC) curves, followed by a comparative analysis with five pre-existing scores.Results: A total of 140 patients were included in the study. The CHAMPS score showed its highest performance in predicting mortality rates (AUROC = 0.89), significantly outperforming the Glasgow-Blatchford Bleeding Score (GBS) as well as the Albumin level < 3.0 mg/dL, International normalized ratio > 1.5, altered Mental status, Systolic blood pressure ≤ 90 mmHg, and age > 65 years (AIMS65) score (AUROC = 0.72 and 0.71, respectively; all p < 0.05). Subgroup analysis for bleeding-related and non-bleeding-related mortality further confirmed the robust predictive capability of the CHAMPS score (AUROC = 0.88 and 0.87, respectively). The CHAMPS score failed to predict rebleeding and intervention reliably, exhibiting AUROC values of 0.43 and 0.55, respectively. The optimal CHAMPS score cutoff value for predicting mortality was 3 points, achieving 100% sensitivity and 71.2% specificity. In the low-risk category defined by both CHAMPS and GBS scores, mortality and rebleeding rates were 0%. However, within the CHAMPS score-based low-risk group, 58.8% required intervention, contrasting with a 0% intervention rate for the GBS score-based low-risk group (GBS score ≤ 1).Conclusion: The CHAMPS score consistently demonstrated a robust predictive performance for mortality (AUROC > 0.8), facilitating the identification of high-risk patients requiring aggressive treatment and low-risk patients in need of localized treatment or safe discharge after successful bleeding control.Keywords: non-variceal upper gastrointestinal bleeding, CHAMPS, mortality prediction, risk scores, GBS
- Published
- 2024